Loading...

Evaluation of Targeting Efficiency of Joints with Anticollagen II Antibodies

Diseases of the joints affect over 10% of the world’s population, resulting in significant morbidity. There is an unmet need in strategies for specific delivery of therapeutics to the joints. Collagen type II is synthesized by chondrocytes and is mainly restricted to the cartilage and tendons. Arthr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Pharm
Main Authors: Lofchy, Laren A., Vu, Vivian P., Banda, Nirmal K., Ramirez, Joseline Ramos, Smith, Weston J., Gifford, Geoffrey, Gaikwad, Hanmant, Scheinman, Robert I., Simberg, Dmitri
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6777350/
https://ncbi.nlm.nih.gov/pubmed/31091104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.molpharmaceut.9b00059
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!